Hormone Replacement Therapy

Department of Health and Social Care written question – answered on 15th November 2021.

Alert me about debates like this

Photo of Claire Hanna Claire Hanna Social Democratic and Labour Party, Belfast South

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 November 2021 to Questions 65535 and 65536 on Hormone Replacement Therapy, for what reason HRT drugs and products have been affected by supply issues.

Photo of Claire Hanna Claire Hanna Social Democratic and Labour Party, Belfast South

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 November 2021 to Questions 65535 and 65536 on Hormone Replacement Therapy, what the nature of the issues was affecting the supplies of some HRT drugs and products.

Photo of Edward Argar Edward Argar Minister of State (Department of Health and Social Care)

Supply issues that have affected the availability of hormone replacement therapy (HRT) preparations include manufacturing issues, regulatory issues, problems accessing the raw pharmaceutical ingredient as well as commercial decisions made by some companies to divest these products.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.